We are delighted to announce that registration is now open for the upcoming 7th European conference dedicated to pediatric pulmonary hypertension, pulmonary vascular disease, and cardiac adaptation from infancy through adolescence.

This meeting will bring together leading clinicians, researchers, allied healthcare professionals, and trainees from around the world to explore the latest advances in diagnosis, pathobiology, imaging, risk stratification, intervention, and treatment of pulmonary vascular disease in children.

Through inspiring keynote lectures, state-of-the-art scientific sessions, interactive case discussions, and networking opportunities, the conference will provide a unique platform to exchange knowledge, challenge current paradigms, and shape the future of care for children with pulmonary vascular disease.

Whether your expertise lies in pediatric cardiology, neonatology, pediatric pulmonology, intensive care, imaging, genetics, nursing, research, or allied health professions, this conference offers valuable insights for all professionals committed to improving outcomes for children with these complex conditions.

Why attend?

• Learn from internationally renowned experts

• Discover the latest scientific and clinical developments

• Engage in multidisciplinary discussions and challenging case reviews

• Connect with colleagues and collaborators from across the globe

• Gain practical insights that can be directly applied to patient care

Together, we will explore the challenges and opportunities that define the next era of pediatric pulmonary vascular medicine, including:

 

• Pediatric Pulmonary Hypertension

An orphan disease with many faces? navigating prevalence and heterogeneity

• Risk stratification in pediatric PAH

Pediatric Risk scores: clinical tool or false reassurance?

• Genetic testing in neonatal pulmonary vascular disease

Precision care or premature labeling?

• Pulmonary Vascular Development

Small babies, big consequences: Is IUGR a lifelong vascular disease?

• Genotype phenotype correlations in pulmonary vascular disease

One variant divergent outcomes: why phenotype refuses to follow the script

• Treatment challenges in pediatric PH

Precision therapy or treatment algorithms: who wins?

• Congenital Heart disease and Pulmonary Vascular Disease

Close, treat or wait: who dares to decide in the grey zone?

• Computational Modeling and AI in pulmonary hypertension

Predicting the future, or just fitting the past?​

• Current evidence in neonatal and pediatric pulmonary vascular disease

From clinical experience, trials and registries: are we making any progress?

​

• Special Friday Afternoon Programme

Celebrating the Step-Down of Professor Dr. Rolf Berger, followed by a Reception

Register now and secure your place.

​

We look forward to welcoming you for an inspiring and impactful meeting.

Advancing science. Improving care. Changing lives.

​

The detailed program will follow soon